Direktorat Registrasi ObatValid

LAMICTAL

BPOM Number: DKI1433900281B1
Approved: 21 November 2024
Expiry: 6 September 2027
Form: TABLET DISPERSIBLE; 25.00 MG

About This Registration

LAMICTAL is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI1433900281B1. Its current registration status is Valid, with the licence valid until 6 September 2027. The product is registered to GLAXO WELLCOME INDONESIA - INDONESIA. BPOM first approved this registration in September 2022. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: Registrasi Obat
Packaging: DUS, 3 BLISTER @ 10 TABLET DISPERSIBEL
Department: Direktorat Registrasi Obat
Data Last Updated: 13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

GLAXO WELLCOME INDONESIA - INDONESIA
KODYA JAKARTA TIMUR
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

GLAXO WELLCOME INDONESIA - INDONESIA
KODYA JAKARTA TIMUR
primary
View profile →

Ingredients (1)

LAMOTRIGINE

Market Intelligence

Owner Portfolio: GLAXO WELLCOME INDONESIA - INDONESIA holds 75 BPOM registrations
Manufacturer Scale: GLAXO WELLCOME INDONESIA - INDONESIA produces 75 registered products
Registration Age: Registered for 4 years
Expiry Status: Expires in 11 months

FDA Cross-Reference

via openFDA

Generic Name: LAMOTRIGINE
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?